Clinical Trial Update: A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study of bulevirtide in participants with normal or impaired renal function for chronic hepatitis D infection; results from the completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Bulevirtide (Hepcludex) (bulevirtide)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis D Infection | Phase 1 | Status: COMPLETED | Results posted: 2025-09-18